Hyderabad Telangana, India

Srihari Raju Kalidindi

This inventor holds 8 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Laurus Labs Private Limited. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srihari Raju Kalidindi. Retrieved from https://idiyas.com/inventor/srihari-raju-kalidindi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 75.0

 

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Srihari Raju Kalidindi: Innovator in Pharmaceutical Compositions

Introduction

Srihari Raju Kalidindi is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid forms of SGLT2 inhibitors. With a total of 8 patents to his name, Kalidindi's work has the potential to impact therapeutic applications significantly.

Latest Patents

One of his latest patents focuses on co-crystals of SGLT2 inhibitors, detailing the processes for their preparation and the pharmaceutical compositions derived from them. This invention provides solid forms of SGLT2 inhibitors, outlines processes for their purification, and discusses their therapeutic uses. The innovative approach taken in this patent showcases Kalidindi's commitment to advancing pharmaceutical science.

Career Highlights

Throughout his career, Srihari Raju Kalidindi has worked with notable companies such as Laurus Labs Private Limited and Pharmis Biofarmacêutica, Lda. His experience in these organizations has allowed him to hone his skills and contribute to significant advancements in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Venkata Sunil Kumar Indukuri and Satyanarayana Chava. Their collaborative efforts have likely played a role in the successful development of various projects and patents.

Conclusion

Srihari Raju Kalidindi stands out as an influential inventor in the pharmaceutical sector, with a focus on SGLT2 inhibitors and their applications. His contributions through patents and collaborations continue to shape the future of therapeutic innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…